Philadelphia Trust CO Merck & Co., Inc. Transaction History

Philadelphia Trust CO

  • $1.38 Billion
  • Q3 2024

A detailed history of Philadelphia Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Philadelphia Trust CO holds 57,291 shares of MRK stock, worth $5.62 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
57,291
Previous 47,202 21.37%
Holding current value
$5.62 Million
Previous $5.84 Million 11.33%
% of portfolio
0.47%
Previous 0.45%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$111.15 - $128.97 $1.12 Million - $1.3 Million
10,089 Added 21.37%
57,291 $6.51 Million
Q2 2024

Aug 13, 2024
BUY
$123.8 - $132.96 $21,417 - $23,002
173 Added 0.37%
47,202 $5.84 Million
Q1 2024

May 13, 2024
SELL
$113.24 - $131.95 $63,867 - $74,419
-564 Reduced 1.19%
47,029 $6.21 Million
Q4 2023

Feb 09, 2024
SELL
$100.18 - $109.02 $2,504 - $2,725
-25 Reduced 0.05%
47,593 $5.19 Million
Q3 2023

Nov 09, 2023
BUY
$102.95 - $114.33 $88,022 - $97,752
855 Added 1.83%
47,618 $4.9 Million
Q2 2023

Aug 07, 2023
SELL
$108.61 - $118.38 $139,238 - $151,763
-1,282 Reduced 2.67%
46,763 $5.4 Million
Q1 2023

May 12, 2023
SELL
$102.94 - $114.86 $5,661 - $6,317
-55 Reduced 0.11%
48,045 $5.11 Million
Q4 2022

Feb 07, 2023
SELL
$87.44 - $112.11 $423,034 - $542,388
-4,838 Reduced 9.14%
48,100 $5.34 Million
Q3 2022

Nov 10, 2022
BUY
$84.53 - $94.96 $382,751 - $429,978
4,528 Added 9.35%
52,938 $4.56 Million
Q2 2022

Aug 15, 2022
BUY
$83.49 - $94.64 $55,437 - $62,840
664 Added 1.39%
48,410 $4.41 Million
Q1 2022

May 05, 2022
BUY
$73.51 - $82.4 $67,776 - $75,972
922 Added 1.97%
47,746 $3.92 Million
Q4 2021

Feb 09, 2022
SELL
$72.28 - $90.54 $128,297 - $160,708
-1,775 Reduced 3.65%
46,824 $3.59 Million
Q3 2021

Nov 15, 2021
SELL
$71.68 - $78.83 $107,376 - $118,087
-1,498 Reduced 2.99%
48,599 $3.65 Million
Q2 2021

Aug 13, 2021
SELL
$70.31 - $77.77 $77,411 - $85,624
-1,101 Reduced 2.15%
50,097 $3.9 Million
Q1 2021

May 14, 2021
SELL
$68.86 - $81.11 $309,525 - $364,589
-4,495 Reduced 8.07%
51,198 $3.95 Million
Q4 2020

Feb 08, 2021
BUY
$71.77 - $79.65 $94,018 - $104,341
1,310 Added 2.41%
55,693 $4.56 Million
Q3 2020

Nov 12, 2020
BUY
$73.18 - $82.95 $382,950 - $434,077
5,233 Added 10.65%
54,383 $4.51 Million
Q2 2020

Aug 14, 2020
SELL
$70.42 - $80.13 $44,646 - $50,802
-634 Reduced 1.27%
49,150 $3.8 Million
Q1 2020

May 12, 2020
SELL
$63.36 - $87.82 $594,443 - $823,927
-9,382 Reduced 15.86%
49,784 $3.83 Million
Q4 2019

Feb 10, 2020
BUY
$77.58 - $87.54 $16,136 - $18,208
208 Added 0.35%
59,166 $5.38 Million
Q3 2019

Nov 12, 2019
BUY
$76.08 - $82.93 $642,115 - $699,929
8,440 Added 16.71%
58,958 $4.96 Million
Q2 2019

Aug 08, 2019
SELL
$69.84 - $81.59 $220,135 - $257,171
-3,152 Reduced 5.87%
50,518 $4.24 Million
Q1 2019

May 15, 2019
BUY
$69.58 - $79.36 $2.09 Million - $2.38 Million
30,025 Added 126.98%
53,670 $4.46 Million
Q4 2018

Feb 13, 2019
SELL
$65.24 - $75.71 $97,859 - $113,564
-1,500 Reduced 5.97%
23,645 $1.81 Million
Q3 2018

Nov 14, 2018
BUY
$57.69 - $67.84 $9,807 - $11,532
170 Added 0.68%
25,145 $1.78 Million
Q2 2018

Aug 10, 2018
BUY
$50.83 - $59.72 $3,812 - $4,479
75 Added 0.3%
24,975 $1.52 Million
Q1 2018

May 14, 2018
SELL
$50.96 - $59.23 $128,113 - $148,904
-2,514 Reduced 9.17%
24,900 $1.36 Million
Q4 2017

Feb 14, 2018
SELL
$51.62 - $61.64 $64,525 - $77,050
-1,250 Reduced 4.36%
27,414 $1.54 Million
Q3 2017

Nov 13, 2017
BUY
$58.67 - $63.13 $1.68 Million - $1.81 Million
28,664
28,664 $1.84 Million

Others Institutions Holding MRK

# of Institutions
3,827
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Philadelphia Trust CO Portfolio

Follow Philadelphia Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Philadelphia Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Philadelphia Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email